| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
The Galveston County Health District includes both childhood and adult immunizations in its strategic health plan which is a tool guiding their activities through 2010.
StartUp Health is organizing and supporting a global army of Health Transformers working on 10 Health Moonshots to improve the health and wellbeing of everyone in the world.
Applied Biometrics is a Glendale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MicroAire Surgical Instruments is a Charlottesville, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.